1,904
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Cinnoline derivatives as human neutrophil elastase inhibitors

, , , , , , , & show all
Pages 628-639 | Received 11 Mar 2015, Accepted 06 May 2015, Published online: 21 Jul 2015

References

  • Korkmaz B, Moreau T, Gauthier F. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions. Biochimie 2008;90:227–42
  • Korkmaz B, Horwitz MS, Jenne DE, Gauthier F. Neutrophil Elastase, Proteinase 3, and Cathepsin G as therapeutic targets in human diseases. Pharmacol Rev 2010;62:726–59
  • Bode W, Meyer E, Powers JC. Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, suelaabstrate specificity, and mechanism-based inhibitors. Biochemistry 1989;28:1951–63
  • Chua F, Laurent GJ. Neutrophil elastase: mediator of extracellular matrix destruction and accumulation. Proc Am Thorac Soc 2006;3:424–7
  • Geraghty P, Rogan MP, Greene CM, et al. Neutrophil elastase up regulates cathepsin B and matrix metalloproteinase-2 expression. J Immunol 2007;178:5871–8
  • Bergin DA, Greene CM, Sterchi EE, et al. Activation of the epidermal growth factor receptor (EGFR) by a novel metalloprotease pathway. J Biol Chem 2008;283:31736–44
  • Tremblay GM, Janelle MF, Bourbonnais Y. Anti-inflammatory activity of neutrophil elastase inhibitors. Current Opin Investig Drugs 2003;4:556–65
  • Heutinck KM, ten Berge IJ, Hack CE, et al. Serine proteases of the human system in health and disease. Mol Immunol 2010;47:1943–55
  • O’Donnell R, Peebles A, Ward C, et al. Relationship between peripheral airway dysfunction, airway obstruction and neutrophil inflammation in COPD. Thorax 2004;59:837–42
  • Voynow JA, Fisher BM, Zheng S. Proteases and cystic fibrosis. Int J Biochem Cell B 2008;40:1238–45
  • Gifford AM, Chalmers JD. The role of neutrophils in cystic fibrosis. Curr Opin Hematol 2014;21:16–22
  • Lee WL, Downey GP. Leukocyte elastase: physiological functions and role in acute lung injury. Am J Respir Crit Care Med 2001;164:896–904
  • Tsushima K, King LS, Aggarwal NR, et al. Acute lung injury. Intern Med 2009;48:621–30
  • Meyer-Hoffert U, Wingertszahn J, Wiedow O. Human leukocyte elastase induces keratinocyte proliferation by epidermal growth factor receptor activation. J Invest Dermatol 2004;123:338–45
  • Hilbert N, Schiller J, Arnhold J, Arnold K. Cartilage degradation by stimulated human neutrophils: elastase is mainly responsible for cartilage damage. Bioorg Chem 2002;30:119–32
  • Henriksen PA, Sallenave JM. Human neutrophil elastase: mediator target in atherosclerosis. In J Biochem Cell B 2008;40:1095–100
  • Sato T, Takahashi S, Mizumoto, T, et al. Neutrophil elastase and cancer. Surg Oncol 2006;15:217–22
  • Moroy G, Alix AJ, Sapi J, et al. Neutrophil elastase as a target in lung cancer. Anticancer Agents Med Chem 2012;12:565–79
  • Semple BD, Trivedi A, Gimlin K, Noble-Haeusslein LJ. Neutrophil elastase mediates acute pathogenesis and is a determinant of long-term behavioral recovery after traumatic injury to the immature brain. Neurobiol Dis 2015;74:263–80
  • Groutas WC, Dou D, Alliston KR. Neutrophil elastase inhibitors. Expert Opin Ther Pat 2011;21:339–54
  • Henriksen PA. The potential of neutrophil elastase inhibitors as anti-inflammatory therapies. Curr Opin Hematol 2014;21:23–8
  • Sjö P. Neutrophil elastase inhibitors: recent advances in the development of mechanism based and nonelectrophilic inhibitors. Fut Med Chem 2012;4:651–60
  • Bayer Corp: Prolastin. Company World Wide Web Site. Available from: http://www.bayerdirect.com/pro.htm/ [last accessed 24 Mar 2002]
  • Kawata K, Suzuki M, Sugitani M, et al. ONO-5046, a novel inhibitors of human neutrophil elastase. Biochem Biophys Res Commun 1991;177:814–20
  • Iwata K, Doi A, Ohji G, et al. Effect of neutrophil elastase inhibitors (Sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress (ARDS): a systematic review and meta-analysis. Intern Med 2010;49:2423–32
  • Stockley R, De Soyza A, Gunawardena K, et al. Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis. Respir Med 2013;107:524–33
  • Crocetti L, Giovannoni MP, Schepetkin IA, et al. Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase. Bioorg Med Chem 2011;19:4460–72
  • Crocetti L, Schepetkin IA, Cilibrizzi A, et al. Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase. J Med Chem 2013;56:6259–72
  • Nan G, Ren F, Luo M. Suzuki-Miyaura cross-coupling reaction of 1-aryl-triazenes with arylboronic acids catalyzed by a recyclable polymer-supported N-heterocyclic carbine-palladium complex catalyst. Beilstein J Org Chem 2010;6:1–6
  • Muthupplaniappan M, Margal S, Sukeerthi K, et al. Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation. PTC Int Appl 2009. WO 2009053799 A1 20090430
  • Qiuping D, Wu J. A facile route to 2,4-Dihydro-1H-benzo[d][1,3]thiazines via silver-catalyzed tandem addition-cyclization reaction. J Comb Chem 2008;10:541–5
  • Chakraborty A, Sinha S. Synthesis of 3-[2-(1,3-butadienyl)]-1H-indoles en route to murrapanine analogue. Tetrahedron Lett 2011;52:6635–8
  • Dey R, Ranu BC. A convenient and efficient protocol for the synthesis of 4(1H)-cinnolones, 1,4-dihydrocinnolines, and cinnolines in aqueous medium: application for detection of nitrite ions. Tetrahedron 2011;67:8918–24
  • Haider N, Holzer W. Product class 9: cinnolines. Sci Synth 2004;16:251–313
  • Glówka ML, Iwanicka I, Olczak AJ. Crystal structure communications. Acta Crystallogr C 1994;C50:1770–2
  • Woods KW, Fischer JP, Claiborne A, et al. Synthesis and SAR of indazole-pyridine based protein kinase B/Akt inhibitors. Bioorg Med Chem 2006;14:6832–46
  • Leonard NJ, Boyd SN. Cinnolines. 2. Synthesis of 4-hydroxycinnolines. J Org Chem 1946;11:419–28
  • Tong Y, Penning TD, Florjanuc A, et al. Preparation of substituted fused tricycles as inhibitors of kinase for treating cancer. U.S. Pat Appl Publ 2012. US 20120220572 A1 20120830
  • Schepetkin IA, Khlebnikov AI, Quinn MT. N-Benzoylpyrazoles are novel small-molecule inhibitors of human neutrophil elastase. J Med Chem 2007;50:4928–38
  • Groutas WC, Kuang R, Venkataraman R, et al. Structure-based design of a general class of mechanism-based inhibitors of the serine proteinases employing a novel amino acid-derived heterocyclic scaffold. Biochemistry 1997;36:4739–50
  • Forist AA, Weber DJ. Kinetics of hydrolysis of hypoglycemic 1-acyl 3,5-dimethylpyrazoles. J Pharm Sci 1973;62:318–19
  • Navia MA, McKeever BM, Springer JP, et al. Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84 Å resolution. Proc Natl Acad Sci USA 1989;86:7–11
  • Peters MB, Merz KM. Semiempirical comparative binding energy analysis (SE-COMBINE) of a series of trypsin inhibitors. J Chem Theory Comput 2006;2:383–99
  • Holzer W, Eller GA, Schönberger S. On the tautomerism of cinnolin-4-ol, cinnoline-4-thiol, and cinnolin-4-amine. Heterocycles 2008;75:77–86
  • Stanovnik B, Tišler M, Katritzky AR, Denisko OV. The tautomerism of heterocycles: substituent tautomerism of six-membered ring heterocycles. Adv Heterocycl Chem 2006;91:1–134
  • Bhattacharya S, Sengupta S. Palladium catalyzed alkynylation of aryl halides (Sonogoshira reaction) in water. Tetrahedron Lett 2004;45:8733–6
  • Vergely I, Laugaa P, Reboud-Ravaux M. Interaction of human leukocyte elastase with a N-aryl azetidinone suicide substrate: conformational analyses based on the mechanism of action of serine proteinases. J Mol Graphics 1996;14:158–67

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.